News related to Tylenol (Acetaminophen) and/or conditions it is approved for
BioElectronics Technology More Effective Than Extra Strength Tylenol(R) In Reducing Muscle Soreness In Clinical Study
Source: Pain / Anesthetics News From Medical News Today [2009.11.17]
BioElectronics Corp. (PINKSHEETS: BIEL) announced that its disposable drug-free anti-inflammatory devices proved to be significantly more effective than acetaminophen in a clinical study of Delayed Onset Muscle Soreness (DOMS). The study tested the effectiveness of ActiPatch® Therapy versus acetaminophen in reducing the pain of Delayed Onset Muscle Soreness, a condition associated with increased physical exertion.
Tylenol May Weaken Infant Vaccines
Source: MedicineNet acetaminophen Specialty [2009.10.16]
Title: Tylenol May Weaken Infant Vaccines
Category: Health News
Created: 10/16/2009 9:29:00 AM
Last Editorial Review: 10/16/2009 9:29:30 AM
Some Children's, Infants' Tylenol Recalled
Source: MedicineNet Cystic Fibrosis Specialty [2009.09.25]
Title: Some Children's, Infants' Tylenol Recalled
Category: Health News
Created: 9/25/2009 11:11:00 AM
Last Editorial Review: 9/25/2009 11:11:44 AM
Acetaminophen-Related Liver Damage May Be Prevented By Common Herbal Medicine
Source: Genetics News From Medical News Today [2009.11.18]
A well-known Eastern medicine supplement may help avoid the most common cause of liver transplantation, according to a study by researchers at the Stanford University School of Medicine. The finding came as a surprise to the scientists, who used a number of advanced genetic and genomic techniques in mice to identify a molecular pathway that counters acetaminophen toxicity, which leads to liver failure.
Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review For Intravenous Acetaminophen By Three Months
Source: Pain / Anesthetics News From Medical News Today [2009.11.14]
Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Priority Review of the New Drug Application (NDA) for intravenous (IV) acetaminophen by three months. The extended PDUFA goal date is February 12, 2010.
Acetaminophen could up asthma, wheezing risk (Reuters)
Source: Y! Health Asthma News [2009.11.12]
Reuters - An analysis of 19 studies provides additional evidence of increased asthma risk in children and adults given acetaminophen.
Acetaminophen May Be Linked to Asthma Risk
Source: MedicineNet Aches, Pain, Fever Specialty [2009.11.06]
Title: Acetaminophen May Be Linked to Asthma Risk
Category: Health News
Created: 11/6/2009 10:50:00 AM
Last Editorial Review: 11/6/2009 10:50:12 AM
propoxyphene and acetaminophen, Darvocet A500; Darvocet-N (Darvocet, Wygesic)
Source: MedicineNet Tylenol Liver Damage Specialty [2009.09.10]
Title: propoxyphene and acetaminophen, Darvocet A500; Darvocet-N (Darvocet, Wygesic)
Category: Medications
Created: 3/26/1998 2:30:00 PM
Last Editorial Review: 9/10/2009
FDA May Restrict Acetaminophen
Source: MedicineNet hydrocodone/acetaminophen Specialty [2009.07.01]
Title: FDA May Restrict Acetaminophen
Category: Health News
Created: 7/1/2009
Last Editorial Review: 7/1/2009
hydrocodone/acetaminophen, Vicodin, Vicodin ES, Anexsia, Lorcet, Lorcet Plus, Norco
Source: MedicineNet Coccydynia Specialty [2008.01.07]
Title: hydrocodone/acetaminophen, Vicodin, Vicodin ES, Anexsia, Lorcet, Lorcet Plus, Norco
Category: Medications
Created: 12/31/1997
Last Editorial Review: 1/7/2008
|
